11.2 Follow-up to the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases.

The Medicines Patent Pool (MPP) welcomes the opportunity to comment on the report on the follow-up to the political declaration from the third high-level meeting on the prevention and control of NCDs and notes that improving availability of affordability of essential medicines, including generics, is a key element of the document.

MPP is dedicated to accelerating access to innovative essential medicines in their generic and biosimilar versions through voluntary licensing and technology transfer, to improve affordability, availability and to support regional manufacturing.

To achieve this, MPP remains committed to collaborating with WHO, Member States, and other stakeholders to identify priorities, create a favorable environment for licensing and technology transfer and support the achievement of universal health coverage.